Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Healthcare Medical Devices
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed... see more

Recent & Breaking News (TSX:PRN)

Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire 9 days ago

Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 7, 2024

Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference

GlobeNewswire March 4, 2024

Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure

GlobeNewswire February 27, 2024

Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 - Conference Call to Follow

GlobeNewswire February 15, 2024

Profound Medical Announces Non-Brokered Private Placement

GlobeNewswire January 16, 2024

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues

GlobeNewswire January 3, 2024

Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares

GlobeNewswire December 27, 2023

Profound Medical Announces Proposed Public Offering of Common Shares

GlobeNewswire December 27, 2023

Profound Medical to Participate in the Stifel 2023 Healthcare Conference

GlobeNewswire November 8, 2023

Profound Medical Announces CMS Extension of Temporary 'Code' for TULSA to ASC Setting

GlobeNewswire November 3, 2023

Profound Medical Announces Third Quarter 2023 Financial Results

GlobeNewswire November 2, 2023

Profound Medical to Release Third Quarter 2023 Financial Results on November 2 - Conference Call to Follow

GlobeNewswire October 19, 2023

Profound Medical 2023 Virtual Analyst & Investor Day Agenda

GlobeNewswire October 10, 2023

Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost

GlobeNewswire September 25, 2023

Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13

GlobeNewswire September 21, 2023

Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference

GlobeNewswire September 19, 2023

Profound Medical Announces At-the-Market Offering of up to US$30,000,000

GlobeNewswire September 6, 2023

Profound Medical Announces Second Quarter 2023 Financial Results

GlobeNewswire August 9, 2023

Profound Medical to Release Second Quarter 2023 Financial Results on August 9 - Conference Call to Follow

GlobeNewswire August 2, 2023